Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Godzien J, Kalaska B, Rudzki L, Barbas-Bernardos C, Swieton J, Lopez-Gonzalvez A, et al
Retatrutide is engineered as a single synthetic peptide that simultaneously activates three hormone receptors GLP-1, GIP, and glucagon whereas currently approved medicines target only one or two of these pathways
Some studies of GLP-1 receptor agonists have suggested potential modest effects on stress-related hormonal responses, though findings remain inconsistent and mechanistically unclear
Discovery and engineering of the antibody response to a prominent skin commensal
US$ 25.81
US$ 20.15
US$ 29.31
